MediWound (MDWD) Capital Expenditures Growth (1y) (2014 - 2025)
MediWound (MDWD) Capital Expenditures Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,912.31 Bn | 1,912.25 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.15 Bn | 462.36 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 123.00 Bn | 115.76 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 70.22 Bn | 61.47 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.93 Bn | 62.93 Bn | - | - |
| 8 | Argenx Se | 55.76 Bn | 50.57 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.70 Bn | 34.69 Bn | 959.66 Mn | 143.40% |
| 10 | MediWound | 167.24 Mn | 162.44 Mn | 278,000.00 | 67.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 67.05% |
| Sep 30, 2025 | 12.33% |
| Jun 30, 2025 | 65.22% |
| Mar 31, 2025 | 23.83% |
| Dec 31, 2024 | -52.21% |
| Sep 30, 2024 | 29.26% |
| Jun 30, 2024 | -183.19% |
| Mar 31, 2024 | 16.35% |
| Jun 30, 2023 | -671.74% |
| Mar 31, 2023 | -840.63% |
| Jun 30, 2022 | -430.77% |
| Mar 31, 2022 | 26.61% |
| Dec 31, 2021 | 73.81% |
| Jun 30, 2021 | 74.00% |
| Mar 31, 2021 | -51.39% |
| Dec 31, 2020 | -34.65% |
| Sep 30, 2020 | -686.67% |
| Jun 30, 2020 | 48.45% |
| Mar 31, 2020 | 39.75% |
| Dec 31, 2019 | -151.15% |